ChemLex
- CMO, CRO

ChemLex, headquartered in Singapore, provides disruptive chemical synthesis services to pharmaceutical and biotech partners via its fully-autonomous chemical synthesis platform, powered by AI algorithms. Compared to traditional chemistry synthesis, the AI and automation platform not only improves quality, consistency and delivery efficiency, but also reduces cost and integrates ESG metrics via its quantitative green chemistry system.